Cannabinoids affects on Parkinson’s Disease

Enjoy these links to studies and research on cannabis and various medical condition. Supplementation with cannabinoids will have different effects for each person, we are not medically trained or qualified to give medical advice. We do not suggest that cannabis will treat, cure or prevent any particular medical condition, we merely present these links and research to aid your further investigation.  The majority of these studies are conducted under strict supervision with high doses.

Parkinson’s Disease, is a a very debilitating condition leading to the degeneration of motor functions such as talking and walking.

Cannabidiol (CBD) CBD is reported to have neuro-genesis, neuro-protectant, anti-oxidant and anti-inflammatory qualities; and has been observed to decrease the symptoms of PD allowing for a better quality of life for many sufferers.  Much more research is needed but cannabinoids like CBD could provide much relief for those suffering with PD.  We will be investigating various medical conditions in greater detail so sign up as a NuFriend and we will keep you up to date with our free resources.

Link: Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial.

Study of 119 patients to observe the effects of Cannabidiol (CBD) as to whether it improved motor functions, quality of life, and neuro-protective effects.

Link: Cannabidiol for the treatment of psychosis in Parkinson’s disease.

This study was to directly evaluate for the first time, the efficacy, tolerability and safety of CBD on PD patients with psychotic symptoms.

Link: Prospects for cannabinoid therapies in basal ganglia disorders.

Do cannabinoids with antioxidant properties and/or capability to activate CB(2) receptors represent promising therapeutic agents in HD and PD?

Link: Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson’s Disease.

This study examined whether cannabinoids are effective against the toxicity caused by 6-hydroxydopamine, both in vivo and in vitro, which may be relevant to Parkinson’s disease (PD).


Leave a reply